CorMedix (CRMD)
(Real Time Quote from BATS)
$7.29 USD
+0.28 (3.99%)
Updated Sep 20, 2024 03:02 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 3.85% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.58 |
Next Year | 0.17 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.00M | 17.58M | 29.39M | 100.21M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 11.00M | 17.58M | 29.39M | 100.21M |
Low Estimate | 11.00M | 17.58M | 29.39M | 100.21M |
Year ago Sales | 0.00M | 0.00M | 0.07M | 29.39M |
Year over Year Growth Est. | NA | NA | 44,437.05% | 240.97% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.01 | -0.58 | 0.17 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.10 | -0.01 | -0.58 | 0.17 |
Low Estimate | -0.10 | -0.01 | -0.58 | 0.17 |
Year ago EPS | -0.17 | -0.26 | -0.91 | -0.58 |
Year over Year Growth Est. | 41.18% | 96.15% | 36.26% | 129.31% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.01 | -0.58 | 0.17 |
7 Days Ago | -0.10 | -0.01 | -0.58 | 0.17 |
30 Days Ago | -0.10 | -0.01 | -0.58 | 0.17 |
60 Days Ago | -0.23 | -0.12 | -0.85 | -0.24 |
90 Days Ago | -0.23 | -0.12 | -0.85 | -0.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.01 | -0.58 | 0.17 |
Zacks Consensus Estimate | -0.10 | -0.01 | -0.58 | 0.17 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.25 | -0.26 | -0.17 | NA |
Estimate | -0.26 | -0.27 | -0.21 | -0.21 | NA |
Difference | 0.01 | 0.02 | -0.05 | 0.04 | 0.01 |
Surprise | 3.85% | 7.41% | -23.81% | 19.05% | 1.63% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more